Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Overview of the Proof

There is an enhanced interest in the use of cannabinoids in the therapy of symptoms in cancer and palliative care individuals. Their multimodal action, in spite of restricted efficacy, might make them an eye-catching option, specifically in individuals with a number of concomitant symptoms of mild and moderate intensity. There is proof to indicate  cannabis in the therapy of discomfort, spasticity, seizures, sleep problems, nausea and vomiting, and Tourette syndrome. While the effectiveness of cannabinoids is restricted, it was confirmed in neuropathic discomfort management and mixture with opioids. A fairly favorable adverse effects profile, which includes no depressive impact on the respiratory technique, might make  cannabis complement a rather narrow armamentarium that is in the disposition of a palliative care qualified.